Memantine Hydrochloride
- Product NDC
- 13925-540
- 11-digit product format
- 139250540
- Labeler code
- 13925
- Product ID
- 13925-540_cd1fd2cb-7154-4ef6-ac18-e0646a7be6e9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Memantine Hydrochloride Oral
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Seton Pharmaceuticals
- Application
- ANDA210319
- Marketing category
- ANDA
- Marketing start
- 2020-08-31
- Marketing end
- 2027-03-31
- Substance
- MEMANTINE HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Memantine Hydrochloride
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MEMANTINE HYDROCHLORIDE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JY0WD0UA60 |
| Rxcui | 996740 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13925-540-12 | Memantine Hydrochloride | 360 mL in 1 BOTTLE | SOLUTION | 360 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 13925-540 | MEMANTINE HYDROCHLORIDE (MEMANTINE HYDROCHLORIDE ORAL) SOLUTION [SETON PHARMACEUTICALS] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240131_421f6478-09df-49d3-a7c4-52814b4aa90e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 13925-540-12 | 13925054012 | 360 mL in 1 BOTTLE (13925-540-12) | 360 ml | 2021-05-19 | 2027-03-31 | No | No | Current |